by palligoelme@gmail.com | Sep 19, 2026 | Clinical Trials
Conditions: Liver Failure Interventions: Drug: Anti-Thymocyte Globulin, ATG (Rabbit); Device: Total lymphoid irradiation Sponsors: Stanford University Not yet recruiting Conditions: Liver Failure Interventions: Drug: Anti-Thymocyte Globulin, ATG (Rabbit); Device:...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Proliferative Diabetic Retinopathy (PDR) Interventions: Drug: Ranibizumab 0.5 mg; Procedure: laser photocoagulation (PRP) Sponsors: Aswan University Completed Conditions: Proliferative Diabetic Retinopathy (PDR) Interventions: Drug: Ranibizumab 0.5 mg;...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Allergic Bronchopulmonary Aspergillosis; ABPA; Severe Eosinophilic Asthma Interventions: Drug: Depemokimab Sponsors: Qianfoshan Hospital Not yet recruiting Conditions: Allergic Bronchopulmonary Aspergillosis; ABPA; Severe Eosinophilic Asthma...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Nocturia; Nocturnal Urinary Incontinence Interventions: Drug: TolterodineTartrate ER; Drug: Mirabegron; Drug: Placebo Sponsors: University of California, San Francisco; National Institute on Aging (NIA) Recruiting Conditions: Nocturia; Nocturnal Urinary...
by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials
Conditions: Chronic Pain; Veterans Interventions: Other: Self-Guided Digital Acceptance and Commitment Therapy Program Sponsors: University Health Network, Toronto; Chronic Pain Centre of Excellence for Canadian Veterans Recruiting Conditions: Chronic Pain; Veterans...